ArticleFrontiers in endocrinology2019

Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling.

Fengjuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.